A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2011
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	CA2796575A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
10/20/2011	CA2796311A1 Fused derivatives as pi3k.delta. inhibitors
10/20/2011	CA2796280A1 Topical treatments for pain
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	CA2796083A1 Compositions and methods for treating copd exacerbation
10/20/2011	CA2795078A1 Proteins that bind pi16 and uses thereof
10/20/2011	CA2792278A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2376512A2 Derivatives of morphine-6-glucuronid, process for their preparation and their use in therapy
10/19/2011	EP2376501A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
10/19/2011	EP2376496A2 Synthesis of morphine-6-glucuronide or of a derivative thereof
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376490A1 Imidazopyridine compounds
10/19/2011	EP2376484A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
10/19/2011	EP2376462A1 Thiazoles as cannabinoid receptor ligands
10/19/2011	EP2376104A1 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/19/2011	EP2376079A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/19/2011	EP2376069A2 Microparticles comprising adipose stem cells
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1937250B1 Ligustilide derivatives for the treatment of inflammatory disorders
10/19/2011	EP1917012B1 Cell migration modulating compounds
10/19/2011	EP1891075B1 Tricyclic spiro derivatives as crth2 modulators
10/19/2011	EP1809379B1 Process for preparing (3-(2(r)-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3(s)-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-4,5-dihydro-(1,2,4)-triazol-1-yl) phosphonic acid
10/19/2011	EP1735332B1 Azacyclosteroid histamine-3 receptor ligands
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN102224154A Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists
10/19/2011	CN102224153A Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
10/19/2011	CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102223889A Homeopathic therapeutic method
10/19/2011	CN102220216A Acanthopanax sessiliflorus white spirit and brewing method thereof
10/19/2011	CN102220215A Health-care wine
10/19/2011	CN102219811A CA-4 derivatives and preparation method and medicinal application thereof
10/19/2011	CN102219727A Synthesis method of compound indometacin-feruloyl esterase
10/19/2011	CN102218196A Far-infrared ionic heat penetration treatment belt
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218130A Pharmaceutical composition for treating arthralgia syndrome and preparation method thereof
10/19/2011	CN102218129A New drug delivery system of gynaecologic panchrest plaster
10/19/2011	CN102218124A Special traditional Chinese medicine wine for oral administration for treating rheumatism bone disease
10/19/2011	CN102218119A Chinese herbal medicine for treating rheumatism, femoral head necrosis and puerperal fever
10/19/2011	CN102218117A Fire treatment liquid embrocation for external application and preparation method thereof
10/19/2011	CN102218103A Application of extractive of adinandra nitida leaves to preparation of anti-inflammatory analgesia medicament
10/19/2011	CN102218095A Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
10/19/2011	CN102218094A Chinese medicinal preparation for treating traumatic injury and preparation method thereof
10/19/2011	CN102218090A Rice roasting processing method of traditional Chinese medicine salvia miltiorrhiza bunge
10/19/2011	CN102218089A Chinese medicine preparation capable of increasing bone density and improving osteoporosis and arthralgia
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218074A Transdermal patch containing paeoniflorin and glycyrrhetinic acid and method for preparing same
10/19/2011	CN102218071A Micronized deflazacort oral preparation and preparation method thereof
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218043A LDH (Layered Double Hydroxides) supermolecular assembly type aspirin sustained release tablet and preparation method thereof
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101987118B Food therapy health care wine for treating rheumatoid diseases and rheumatism
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101757014B Medicament for treating periodontal disease
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101574413B Traditional Chinese medicine preparation for curing rheumatoid arthritis and preparation method thereof
10/19/2011	CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011	CN101181601B Externally used detumescence ding-tong wine for curing orthopaedics illness
10/19/2011	CN101095671B Iguratimod oral double-layer sustained-release preparation
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2419842C New aporphine esters and their use in therapy
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/13/2011	WO2011127324A2 Antibodies to cd122
10/13/2011	WO2011127302A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	WO2011127048A2 NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126833A2 Anti-inflammatory factors
10/13/2011	WO2011123942A1 Fatty acid derivatives of catechins and methods of their use
10/13/2011	WO2011071296A3 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica
10/13/2011	WO2011069149A3 Cathepsin s inhibitors
10/13/2011	WO2011059609A9 Dendrimer compositions and methods of synthesis
10/13/2011	WO2011056972A9 Compositions and methods of treating a t cell mediated disorder
10/13/2011	WO2011047040A3 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells
10/13/2011	WO2011038086A3 Indolizine inhibitors of 5-lipoxygenase
10/13/2011	US20110251566 Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
10/13/2011	US20110251287 Hci polymorphs of 3-((2-(dimethylamino)methyl (cyclohex-1-yl))phenol
10/13/2011	US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol
10/13/2011	US20110251268 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
10/13/2011	US20110251266 Aptamer for ngf and use thereof
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251227 Analgesic agents
10/13/2011	US20110251224 Spiro-oxindole compounds and their uses as therapeutic agents
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251211 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1272